Carbimazole - Isotope Labelled Standards
References
FAQ's
References
- Rimington, Claude; Lawson, Alexander; Searle, Charles E.; Morley, Harold V., Certain substituted thioglyoxalones, US2815349A, Dec 3, 1957, National Research Development Corp. (https://www.lens.org/lens/search/patent/list?q=US2815349)
- El-Bardicy, M. G.; El-Saharty, Y. S.; Tawakkol, M. S., Determination of carbimazole and methimazole by first and third derivative spectrophotometry, Spectroscopy Letters, Volume: 24, Issue: 9, Pages: 1079-95, 1991 DOI: (10.1080/00387019108018174)
Frequently Asked Questions
2. Which analytical methods separate and qualify the main Carbimazole impurity and degradation product from the drug product?
Stability-indicating HPLC and HPTLC methods separate and qualify the main Carbimazole impurity and degradation product from the drug product.
3. How do the degradation products of Carbimazole form?
The degradation products of Carbimazole are formed under thermal, photolytic, oxidative, and hydrolytic conditions.
4. Which analytical methods confirm the degradation products of Carbimazole?
MS and IR spectroscopy are the methods to characterize and confirm the degradation products of Carbimazole.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.